1Chobanian AV,Bakris G L,Black HR et al.The seventh report of the joint motional committee on prevention,Detection,Evaluation,and Treatment of high blood pressure.JAMA,2003,289(19):2 560.
2Zannad F,Alla F,Dousset B et al.Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure. Circulation,2000,2:2 700.
3Pitt B,Byington RP,Furberg CD et al.Effect of amlodipine on the protression of atherosclerosis and the occurrence of clinical eve-nts.PREVENT Investigators.Circulation,2000,102:1 503.
5Book WM.Carvedilol:A nonselective beta blocking agent with antioxidant properties.Congest-Heart-Fail,2002,8:173.
6Estacio RO,Jeffers BN,Hialt WR et al.The effect of nisoldipine as compared with enalapric on cardiovascular outcomes in patients with hon-insulin-dependent diabetes and hypertension.W Eng1 J Med,1998,338:645.
9Leonetti G,Zanchetti A.Results of antihypertensive treatment trials in the elderly.Am J Geriatr Cardiol,2002,11(1):41.
10Kaplan NM.Newissues in the treatment of isolated systolic hypertension.Circulation,2000,102:1 079.
二级参考文献17
1Weiss D, Kools JJ, Taylor WR. Angiotensin Ⅱ-induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice. Circulation, 2001, 103: 448-454.
2Li J, Hirose N, Kawamura M, et al. Antiatherogenetic effect of angiotensin converting enzyme inhibitor(benazepril) and angiotensin Ⅱ receptor antagonist(valsartan) in the cholesterol-fed rabbits. Atherosclerosis, 1999, 143: 315-326.
3Brand K, Page S, Rogler G, et al. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic leision. J Clin Invest, 1996, 97: 1715-1722.
4Baeuerie PA, Henkel T. Function and activation of NF-κB in the immune system. Annu Rev Immunol, 1994, 12: 141-179.
5Ritchie ME. Nuclear factor-κB selectively and markedly activated in humans with unstable angina pectoris. Circulation, 1998, 98: 1707-1713.
6Wilson SH, Caplice NM, Simari RD, et al. Activated nuclear factor-κB is present in the coronary vasculature in experimental hypercholes-terolemia. Atherosclerosis, 2000, 148: 23-30.
4Lloyd-Jones DM, Evans JC, Levy D. Hypertension in adults across the age spectrum: Current outcomes and control in the community [J].JAMA,2005,294(4):466 472.
